132
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Modeling the Survival of Tuberculosis Patients in Eastern Zone of Tigray Regional State

ORCID Icon
Pages 473-481 | Published online: 25 May 2020

References

  • WHO. Global Tuberculosis Report 2018. Geneva: World Health Organization; 2018 doi:WHO/HTM/TB/2017.23
  • World Health Assembly. Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015 (WHA67.1, Agenda Item 12.1). Geneva: World Health Assembly; 2015
  • Olaleye A, Beke A. Determinants of Survival of Patients with Tuberculosis in Developing Countries In: Tuberculosis. 2018. doi:10.5772/intechopen.75890
  • Federal Ministry of Health. Guidelines for Clinical and Programmatic Management of TB, TB/HIV and Leprosy in Ethiopia. 5th Addis Ababa; 2012.
  • FDRE Ministry of Health. Health Sector Transformation Plan. Addis Ababa, Ethiopia; 2015.
  • Heunis JC, Kigozi NG, Chikobvu P, Botha S, Van Rensburg HD. Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province. BMC Public Health. 2017;17. doi:10.1186/s12889-016-3972-2.
  • Beyene Y, Geresu B, Mulu A. Mortality among tuberculosis patients under DOTS programme: a historical cohort study. BMC Public Health. 2016;16. doi:10.1186/s12889-016-3557-0.
  • Birlie A, Tesfaw G, Dejene T, Woldemichael K. Time to death and associated factors among tuberculosis patients in dangila woreda, northwest Ethiopia. PLoS One. 2015;10:e0144244. doi:10.1371/journal.pone.014424426669737
  • Takarinda KC, Sandy C, Masuka N, et al. Factors associated with mortality among patients on TB treatment in the Southern region of Zimbabwe, 2013. Tuberc Res Treat. 2017. doi:10.1155/2017/6232071
  • Aljohaney AA. Mortality of patients hospitalized for active tuberculosis in King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Saudi Med J. 2018;39(3):267–272. doi:10.15537/smj.2018.3.2228029543305
  • Central Statistical Agency. Population and Housing Census of 2007. Ethiopia; 2007.
  • Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-48668867
  • Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972. doi:10.1111/j.2517-6161.1972.tb00899.x
  • Berhe G, Enquselassie F, Aseffa A. Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia. BMC Public Health. 2012;12(1). doi:10.1186/1471-2458-12-537
  • Asgedom SW, Tesfaye D, Nirayo YL, Atey TM. Time to death and risk factors among tuberculosis patients in Northern Ethiopia. BMC Res Notes. 2018;11. doi:10.1186/s13104-018-3806-7.
  • Adamu AL, Gadanya MA, Abubakar IS, et al. High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study. BMC Infect Dis. 2017;17. doi:10.1186/s12879-017-2249-4
  • Sinshaw Y, Alemu S, Fekadu A, Gizachew M. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study. BMC Infect Dis. 2017;17. doi:10.1186/s12879-017-2238-7.
  • Shaweno D, Worku A. Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: a retrospective cohort study. BMC Res Notes. 2012;5. doi:10.1186/1756-0500-5-682.
  • Jonnalagada S, AD H, Zachariah R, et al. The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India. BMC Public Health. 2011;11. doi:10.1186/1471-2458-11-921
  • Alobu I, Oshi SN, Oshi DC, Ukwaja KN. Risk factors of treatment default and death among tuberculosis patients in a resource-limited setting. Asian Pac J Trop Med. 2014;7:977–984. doi:10.1016/S1995-7645(14)60172-325479627
  • Gayoso R, Dalcolmo M, Braga JU, Barreira D. Predictors of mortality in multidrug-resistant tuberculosis patients from Brazilian reference centers, 2005 to 2012. Brazilian J Infect Dis. 2018;22:305–310. doi:10.1016/j.bjid.2018.07.002
  • Alavi-Naini R, Moghtaderi A, Metanat M, Mohammadi M, Zabetian M. Factors associated with mortality in tuberculosis patients. J Res Med Sci. 2013;18(1):52.23901338
  • Woldeamanuel GG, Mingude AB. Factors associated with mortality in tuberculosis patients at Debre Birhan Referral Hospital, Ethiopia: a retrospective study. J Trop Dis. 2018;07. doi:10.4172/2329-891x.1000289.
  • Montgomery RR, Shaw AC. Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol. 2015;98:937–943. doi:10.1189/jlb.5mr0315-104r26188078
  • Vasantha M, Gopi PG, Subramani R. Survival of tuberculosis patients treated under DOTS in a rural Tuberculosis Unit (TU), south India. Indian J Tuberc. 2008;55(2):64–69.18516821
  • Keusch GT. Malnutrition, infection, and immune function In: Suskind RM, Lewinter-Suskind L, editors. Nestle Nutrition Workshop Series. USA: Nestec Ltd., Vevey/Raven Press, Ltd.; 1990.
  • Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis. 2002;(6):752–759. doi:10.1086/33878411850859
  • Ranzani OT, Rodrigues LC, Bombarda S, Minto CM, Waldman EA, Carvalho CRR. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study. Lancet Infect Dis. 2020;20(1):123–132. doi:10.1016/S1473-3099(19)30518-331676242
  • Workneh MH, Bjune GA, Yimer SA. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia. Infect Dis Poverty. 2016;5. doi:10.1186/s40249-016-0115-z.
  • Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998;114:1244–1252. doi:10.1378/chest.114.5.12449823996
  • Chan CK, Wong KH, Lee MP, et al. Risk factors associated with 1-year mortality among patients with HIV-associated tuberculosis in areas with intermediate tuberculosis burden and low HIV prevalence. Hong Kong Med J. 2018;24(5):473–483. doi:10.12809/hkmj18730330262675
  • Pardeshi G. Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course. Indian J Med Sci. 2009;63:180. doi:10.4103/0019-5359.5316319584488
  • Tocque K, Convrey RP, Bellis MA, Beeching NJ, Davies PD. Elevated mortality following diagnosis with a treatable disease: tuberculosis. Int J Tuberc Lung Dis. 2005;9(7):797–802.16013777
  • Balaky STJ, Mawlood AH, Shabila NP. Survival analysis of patients with tuberculosis in Erbil, Iraqi Kurdistan region. BMC Infect Dis. 2019;19. doi:10.1186/s12879-019-4544-8.
  • Djouma FN, Noubom M, Ngomba AV, Donfack H, Kouomboua PSM, Saah MAF. Determinants of death among tuberculosis patients in a semi urban diagnostic and treatment centre of Bafoussam, West Cameroon: a retrospective case-control study. Pan Afr Med J. 2015;22. doi:10.11604/pamj.2015.22.253.6576.
  • Pang Y, An J, Shu W, et al. Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008–2017. Emerg Infect Dis. 2019;25(3):457–464. doi:10.3201/eid2503.18057230789144
  • Khazaei HA, Rezaei N, Bagheri GR, et al. Epidemiology of tuberculosis in the southeastern Iran. Eur J Epidemiol. 2005;20:879–883. doi:10.1007/s10654-005-2152-y16283479